Logo image of HTA

HEALTHCARE TRUST OF AME-CL A (HTA) Stock Earnings & Estimates

NYSE:HTA - US42225P5017 - REIT

29.19 USD
-0.02 (-0.07%)
Last: 7/20/2022, 8:04:00 PM
29.23 USD
+0.04 (+0.14%)
After Hours: 7/20/2022, 8:04:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
HTA revenue by date.HTA revenue by date.
692M
-0.63%
739M
6.79%
767.07M
3.80%
822.5M
7.23%
843.127M
2.51%
884.147M
4.87%
907.665M
2.66%
941.126M
3.69%
EBITDA
YoY % growth
HTA ebitda by date.HTA ebitda by date.
429.8M
-0.58%
448.3M
4.30%
459.95M
2.60%
524.007M
13.93%
550.168M
4.99%
560.968M
1.96%
574.729M
2.45%
594.717M
3.48%
EBIT
YoY % growth
HTA ebit by date.HTA ebit by date.
148.8M
-7.52%
165.3M
11.09%
176.65M
6.87%
195.909M
10.90%
212.836M
8.64%
226.173M
6.27%
240.625M
6.39%
258.559M
7.45%
Operating Margin
HTA operating margin by date.HTA operating margin by date.
21.50%22.37%23.03%23.82%25.24%25.58%26.51%27.47%
EPS
YoY % growth
HTA eps by date.HTA eps by date.
0.24
9.09%
0.240.44
83.33%
0.42
-3.59%
0.47
10.32%
0.55
16.55%
0.61
12.31%
0.69
13.43%

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 22 Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth
0.09
-46.53%
0.10
1.00%
0.10
44.29%
0.10
26.25%
0.10
11.11%
0.100.10
Revenue
Q2Q % growth
200.536M
6.32%
201.596M
5.40%
201.142M
2.78%
208.435M
3.19%
209.3M
4.37%
213.275M
5.79%
214.127M
6.46%
EBITDA
Q2Q % growth
128.472M
-31.43%
128.775M
-49.93%
130.189M
-59.90%
135.138M
13.29%
136.401M
6.17%
139.027M
7.96%
140.39M
7.84%
EBIT
Q2Q % growth
51.999M
14.79%
51.584M
14.94%
52.492M
26.79%
53.564M
10.95%
54.558M
4.92%
55.575M
7.74%
56.609M
7.84%

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Q1 2022
Q2Q % growth
0.08
-20.00%
0.11-0.03-24.56%
Q4 2021
Q2Q % growth
0.07
-46.15%
0.10-0.03-32.93%
Q3 2021
Q2Q % growth
0.10
433.33%
0.100.003.14%
Q2 2021
Q2Q % growth
0.17
183.33%
0.110.0660.30%
Q1 2021
Q2Q % growth
0.10
25.00%
0.090.0114.24%
Q4 2020
Q2Q % growth
0.13
225.00%
0.100.0324.06%
Q3 2020
Q2Q % growth
-0.03
-150.00%
0.07-0.10-140.51%
Q2 2020
Q2Q % growth
0.06
-25.00%
0.050.0114.24%
Q1 2020
Q2Q % growth
0.08
33.33%
0.060.0236.57%
Q4 2019
Q2Q % growth
0.04 0.08-0.04-48.34%
Q3 2019
Q2Q % growth
0.06 0.08-0.02-28.71%
Q2 2019
Q2Q % growth
0.08 0.080.001.12%
Q1 2019
Q2Q % growth
0.06 0.07-0.01-18.99%
HTA Yearly EPS VS EstimatesHTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .

PeriodReportedEstimateDifferenceSurprise
Q1 2022
Q2Q % growth
202M
5.48%
200.396M1.604M0.80%
Q4 2021
Q2Q % growth
195.7M
4.65%
194.531M1.169M0.60%
Q3 2021
Q2Q % growth
191.26M
2.11%
193.508M-2.248M-1.16%
Q2 2021
Q2Q % growth
188.62M
5.49%
193.655M-5.035M-2.60%
Q1 2021
Q2Q % growth
191.5M
3.07%
191.747M-247.379K-0.13%
Q4 2020
Q2Q % growth
187M
6.07%
187.855M-855.041K-0.46%
Q3 2020
Q2Q % growth
187.3M
7.03%
184.827M2.473M1.34%
Q2 2020
Q2Q % growth
178.8M
4.07%
184.631M-5.831M-3.16%
Q1 2020
Q2Q % growth
185.8M
9.94%
182.191M3.609M1.98%
Q4 2019
Q2Q % growth
176.3M 178.982M-2.682M-1.50%
Q3 2019
Q2Q % growth
175M 176.098M-1.098M-0.62%
Q2 2019
Q2Q % growth
171.8M 173.037M-1.237M-0.72%
Q1 2019
Q2Q % growth
169M 175.389M-6.389M-3.64%
HTA Yearly Revenue VS EstimatesHTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A